Back to today’s briefing

Story perspectives

2022 Sees 1 in 31 Autism Diagnoses in D.C.

9/25/2025

50 3

Summary

Story summary

Autism diagnoses in 2022 reached 1 in 31 children in Washington, D.C.
Experts say the rise reflects better detection, broader criteria, and access.
Genetic factors account for 80% of autism risk. Environmental influences are significant.
Early intervention improves outcomes; screenings are at 18 and 24 months.
The Food and Drug Administration (FDA) approved leucovorin for autism symptoms; efficacy unclear.

1 of 1

Story summary

Autism diagnoses in 2022 reached 1 in 31 children in Washington, D.C.
Experts say the rise reflects better detection, broader criteria, and access.
Genetic factors account for 80% of autism risk. Environmental influences are significant.
Early intervention improves outcomes; screenings are at 18 and 24 months.
The Food and Drug Administration (FDA) approved leucovorin for autism symptoms; efficacy unclear.